Skip to content

The In Vitro Fertilization - Lipiodol Uterine Bathing Effect Study

The in Vitro Fertilisation - Lipiodol Uterine Bathing Effect Study

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00894946
Enrollment
350
Registered
2009-05-07
Start date
2009-05-31
Completion date
2014-05-31
Last updated
2009-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis, In Vitro Fertilization Implantation Failure

Keywords

recurrent IVF implantation failure

Brief summary

The hypothesis of this study is that Lipiodol uterine bathing improves the success rate of in vitro fertilization (IVF) for women with endometriosis or recurrent IVF implantation failure.

Interventions

PROCEDURELipiodol + IVF

IVF preceded by lipiodol

PROCEDUREIVF

IVF alone

Sponsors

University of Auckland, New Zealand
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

* 12 or more months infertility * Age 18 to 39 * Endometriosis or recurrent IVF implantation failure * Patent fallopian tubes

Exclusion criteria

* Iodine allergy * Blocked fallopian tube or tubes

Design outcomes

Primary

MeasureTime frame
Live birth12 months post-randomization

Secondary

MeasureTime frame
Clinical pregnancy3 months post-randomization
Adverse events3 & 12 months post-randomization

Countries

New Zealand

Contacts

Primary ContactNeil Johnson, MD
n.johnson@auckland.ac.nz+64 274360172
Backup ContactShelley Reilly, MRANZCOG
sreilly@adhb.govt.nz

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026